9,10-dimethyl-1,2-benzanthracene has been researched along with goserelin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kéri, G; Nicholson, RI | 1 |
| Bakker, GH; De Jong, FH; Foekens, JA; Klijn, JG; Portengen, H; Setyono-Han, B | 1 |
| Furr, BJ; Nicholson, RI | 1 |
1 review(s) available for 9,10-dimethyl-1,2-benzanthracene and goserelin
| Article | Year |
|---|---|
Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Tamoxifen | 1982 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and goserelin
| Article | Year |
|---|---|
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Mammary Neoplasms, Experimental; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Time Factors; Uterus | 1992 |
Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cytosol; Drug Implants; Estrenes; Female; Follicle Stimulating Hormone; Goserelin; Injections, Subcutaneous; Luteinizing Hormone; Mammary Neoplasms, Experimental; Mifepristone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |